UC San Diego School of Medicine researchers found that a common measure of alcohol consumption — asking “how often do you have an alcoholic drink?” — is susceptible to bias, and has led to incorrect conclusions about biological influences on…
A new research review identifies personality traits that have been associated with positive and negative experiences on psychedelics being tested for therapeutic purposes in previous studies, information that could help predict how future clinical trial participants will respond to the drugs.
University of South Australia scientists have developed the world’s first test to accurately predict mood disorders in people, based on the levels of a specific protein found in the brain.
“There’s no place like home,” has its roots deep in the brain. Using fiber photometry, scientists are the first to show that home evokes a surge of dopamine in mice that mimics the response to a dose of cocaine. The study demonstrates how dopamine rises rapidly in mice moved from a simple recording chamber to their home cage, but less so when they return to a cage not quite like the one they knew.
The University of Illinois at Chicago has received $5.9 million from the National Institute of Mental Health for two studies that will use cognition data to predict relapses in mood disorders.
Researchers at Mount Sinai have found that a novel class of genes known as long non-coding RNAs (lncRNAs) expressed in the brain may play a pivotal role in regulating mood and driving sex-specific susceptibility versus resilience to depression.
A study published online on Friday, October 4, in The American Journal of Psychiatry found that deep brain stimulation (DBS) of an area in the brain called the subcallosal cingulate (SCC) provides a robust antidepressant effect that is sustained over a long period of time in patients with treatment-resistant depression—the most severely depressed patients who have not responded to other treatments